Jeffrey Mangel is an Obstetrics and Gynecologist in Cleveland, Ohio. Mangel has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in Sacral Nerve Stimulation. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Urinary Incontinence, Stress Urinary Incontinence, Frequent or Urgent Urination, Sacral Nerve Stimulation, and Hysterectomy. Mangel is currently accepting new patients.
Cindy Amundsen is an Obstetrics and Gynecologist in Durham, North Carolina. Amundsen has been practicing medicine for over 32 years and is rated as an Elite expert by MediFind in Sacral Nerve Stimulation. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Urinary Incontinence, Frequent or Urgent Urination, Stress Urinary Incontinence, Sacral Nerve Stimulation, and Hysterectomy. Amundsen is currently accepting new patients.
Howard Goldman is an Urologist and an Obstetrics and Gynecologist in Twinsburg, Ohio. Goldman has been practicing medicine for over 32 years and is rated as an Elite expert by MediFind in Sacral Nerve Stimulation. He is also highly rated in 16 other conditions, according to our data. His top areas of expertise are Urinary Incontinence, Stress Urinary Incontinence, Frequent or Urgent Urination, Sacral Nerve Stimulation, and Endoscopy. Goldman is currently accepting new patients.
Summary: Prospective, multi-center, single-arm, seamless phase-pivotal study conducted in participants diagnosed with UUI who have failed or could not tolerate more conservative treatment. The trial will be conducted in two phases. Objective of Phase I: To assess the utilization of the system during the Sacral Nerve Stimulation (SNS) trial period and to help inform the length of hours of daily stimulation ...
Summary: The goal of this observational study is to evaluate efficacy and safety of sacral neuromodulation in neurogenic patients compared to non-neurogenic (idiopathic) patients. [. The main question[s] it aims to answer are: determine efficacy and safety of the therapy in neurogenic patients. compare outcomes of the therapy to idiopathic patients. If there is a comparison group: Researchers will compare ...